









市场行情
/
股票
/
nasdaq-enov
/

Enovis Corp

ENOV

26.840USD

+0.530+2.01%

收盘 12/24, 13:00（美东）报价延迟15分钟

1.53B总市值

亏损市盈率 TTM



Enovis Corp

26.840

+0.530+2.01%

概览公司财务分析

概览

公司

财务

分析

关于 Enovis Corp 公司

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp简介



公司代码ENOV

公司名称Enovis Corp

上市日期May 08, 2008

CEOMcdonald (Damien)

员工数量7367

证券类型Ordinary Share

年结日May 08

公司地址2711 Centerville Road

城市WILMINGTON

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编19808

电话13022529160

网址https://www.enovis.com/

公司代码ENOV

上市日期May 08, 2008

CEOMcdonald (Damien)

Enovis Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

114.51K

+9.57%

Mr. Damien Mcdonald

Chief Executive Officer, Director

102.75K

+6.71%

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-0.90%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Ms. Barbara W. Bodem

Independent Director

10.52K

+168.36%

Dr. Christine Ortiz, Ph.D.

Independent Director

10.52K

+168.36%

Mr. Philip A. Okala

Independent Director

Ms. Angela S. Lalor

Independent Director

名称

名称/职务

职务

持股

持股变动

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

114.51K

+9.57%

Mr. Damien Mcdonald

Chief Executive Officer, Director

102.75K

+6.71%

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-0.90%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

International Reconstructive

144.48M

25.59%

U.S. Reconstructive

129.49M

22.94%

U.S. Bracing & Support

120.85M

21.41%

International P&R

98.90M

17.52%

U.S. Other P&R

70.82M

12.55%

由于公司未披露，未能获取相关数据

业务

地区

业务USD

名称

营收

占比

International Reconstructive

144.48M

25.59%

U.S. Reconstructive

129.49M

22.94%

U.S. Bracing & Support

120.85M

21.41%

International P&R

98.90M

17.52%

U.S. Other P&R

70.82M

12.55%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.92%

The Vanguard Group, Inc.

11.35%

American Century Investment Management, Inc.

8.27%

Dimensional Fund Advisors, L.P.

5.20%

Davenport Asset Management

4.91%

其他

56.36%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.92%

The Vanguard Group, Inc.

11.35%

American Century Investment Management, Inc.

8.27%

Dimensional Fund Advisors, L.P.

5.20%

Davenport Asset Management

4.91%

其他

56.36%

股东类型

持股股东

占比

Investment Advisor

63.50%

Investment Advisor/Hedge Fund

30.16%

Hedge Fund

16.30%

Research Firm

4.93%

Individual Investor

1.59%

Pension Fund

1.18%

Bank and Trust

1.18%

Family Office

0.07%

Sovereign Wealth Fund

0.05%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

617

68.12M

125.63%

2025Q3

641

68.12M

128.26%

-1.19M

2025Q2

651

69.44M

130.24%

+2.07M

2025Q1

629

67.38M

125.09%

-4.06M

2024Q4

625

63.48M

125.04%

+1.28M

2024Q3

599

62.09M

124.13%

-57.94K

2024Q2

602

61.71M

121.92%

+2.05M

2024Q1

635

59.58M

125.47%

-9.23M

2023Q4

647

58.62M

120.02%

+2.97M

2023Q3

636

55.66M

121.59%

+429.23K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

8.02M

14.03%

+1.50M

+22.95%

Jun 30, 2025

The Vanguard Group, Inc.

6.37M

11.14%

+288.04K

+4.74%

Jun 30, 2025

American Century Investment Management, Inc.

4.74M

8.29%

+1.21M

+34.39%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

2.92M

5.11%

-7.00K

-0.24%

Jun 30, 2025

Davenport Asset Management

2.76M

4.82%

-86.99K

-3.06%

Jul 31, 2025

Dorsey Asset Management LLC

2.55M

4.47%

+2.55M

Jun 30, 2025

State Street Investment Management (US)

2.49M

4.35%

+592.50K

+31.27%

Jun 30, 2025

Hood River Capital Management LLC

1.74M

3.04%

+292.95K

+20.31%

Jun 30, 2025

River Road Asset Management, LLC

1.44M

2.52%

+48.04K

+3.45%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

State Street SPDR S&P Health Care Equipment ETF

1.83%

Invesco S&P SmallCap Health Care ETF

1.09%

Invesco S&P SmallCap 600 Pure Value ETF

0.45%

State Street SPDR S&P 600 Small Cap Value ETF

0.25%

iShares S&P Small-Cap 600 Value ETF

0.24%

iShares U.S. Medical Devices ETF

0.21%

Humankind US Stock ETF

0.2%

State Street SPDR S&P SmallCap 600 ESG ETF

0.18%

Avantis US Small Cap Equity ETF

0.18%

Invesco S&P SmallCap 600 Revenue ETF

0.16%

State Street SPDR S&P Health Care Equipment ETF

占比1.83%

Invesco S&P SmallCap Health Care ETF

占比1.09%

Invesco S&P SmallCap 600 Pure Value ETF

占比0.45%

State Street SPDR S&P 600 Small Cap Value ETF

占比0.25%

iShares S&P Small-Cap 600 Value ETF

占比0.24%

iShares U.S. Medical Devices ETF

占比0.21%

Humankind US Stock ETF

占比0.2%

State Street SPDR S&P SmallCap 600 ESG ETF

占比0.18%

Avantis US Small Cap Equity ETF

占比0.18%

Invesco S&P SmallCap 600 Revenue ETF

占比0.16%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

公告日期

类型

比率

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

常见问题

Enovis Corp的前五大股东是谁？



Enovis Corp 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：8.02M，占总股份比例：14.03%。
The Vanguard Group, Inc.持有股份：6.37M，占总股份比例：11.14%。
American Century Investment Management, Inc.持有股份：4.74M，占总股份比例：8.29%。
Dimensional Fund Advisors, L.P.持有股份：2.92M，占总股份比例：5.11%。
Davenport Asset Management持有股份：2.76M，占总股份比例：4.82%。